ARTICLE | Financial News
Adaptimmune completes venture financing
September 29, 2014 7:00 AM UTC
Adaptimmune Ltd., Abingdon, U.K. Business: Cancer, Infectious, Gene/Cell therapy Date completed: 2014-09-25 Type: Venture financing Raised: $104 million Investors: New Enterprise Associates; OrbiMed A...